Philip & Daniele Barach Family Trust Form SCHEDULE 13D/A — Sep 28, 2026
The Philip & Daniele Barach Family Trust filed Amendment No. 3 to its Schedule 13D on Celularity Inc., disclosing a $3.21 million senior secured convertible note purchased on September 24, 2026, plus warrants for 1,177,000 shares at $1.50, lifting its aggregate beneficial ownership to 11,940,187 shares, or 29% of the class. Under a Board Rights Agreement, Celularity's board is fixed at five directors with the Trust designating two; Philip Barach was appointed to the board on September 24, 2026, and Trust approval is required for independent director appointments and certain spending of financing proceeds.
Key figures
- Maturity
- second anniversary of issuance
- Board size
- 5
- Interest rate
- 10% per annum PIK (15% upon Event of Default)
- Trust board designees
- 2
- Shares outstanding issuer
- 29283614
- Conversion price 2026 note
- $1.50 per share
- Conversion price 2027 notes
- $2.00 per share
- September 2026 note principal
- $3,210,000
- September 2026 warrant shares
- 1177000
- September 2026 warrant strike
- $1.50
- Additional 2027 warrant shares
- 1457765
- Trust outstanding shares owned
- 9491270
- Additional 2027 notes max principal
- $2,915,531
- Aggregate beneficial ownership shares
- 11940187
- Beneficial ownership percent of class
- 29%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.